Sirona Biochem Corp V.SBM

Alternate Symbol(s): SRBCF

Healthcare Biotechnology

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.

TSXV:SBM - Post by User

Sirona Biochem Corp

Bullboard Posts

Comment by blomskompskieson Nov 23, 2015 12:39pm

81 Views

Post# 24316220

RE:RE:Skin Lightener deal

I dont think ity's related to their SP. Ive seen lots of stocks currently o the TSX that are under .20 cents. I think you just have to pay more for being listed on the TSX, and they have stricter reporting guidelines and hoops to get through. Just my opinion. It would be great to see it get on the TSX, more publicity for sure.

Bullboard Posts

Level up your trading with BMO InvestorLine’s enhanced features